Stock Fundamentals

Company Information

Company Name
Profound Medical Corp
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: CA74319B5027
CIK: 0001628808
CUSIP: 74319B502
Currency: USD
Full Time Employees: 162
Phone: 647 476 1350
Fiscal Year End: December
IPO Date: Jun 09, 2016
Description:

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Address:

2400 Skymark Avenue, Mississauga, ON, Canada, L4W 5K5

Directors & Officers

Name Title Year Born
Dr. Arun Swarup Menawat MBA, Ph.D. Chairman of the Board & CEO 1955
Dr. Mathieu Burtnyk Ph.D. President 1982
Mr. Rashed Dewan Chief Financial Officer 1968
Mr. Thomas Tamberrino MBA Chief Commercial Officer 1980
Mr. Stephen Kilmer Investor Relations NA
Mr. Matthew Sobczyk C.A., CPA Assistant Corporate Controller NA
Mr. Levant Tinaz Software Developer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 16, 2025 Arun Swarup Menawat N/A Purchase 12.03K $4.73 $56.89K
May 15, 2025 Arun Swarup Menawat N/A Purchase 10.00K $4.33 $43.31K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Fidelity International Ltd 2.34M Mar 31, 2026 6.44% $0.01 6.36%
Gagnon Securities LLC 1.94M Mar 31, 2026 5.35% $2.91 0.01%
Royce & Associates, LP 1.12M Mar 31, 2026 3.07% $0.07 12.72%
Timelo Investment Management Inc. 1.11M Mar 31, 2026 3.07% $5.70 13.78%
Gagnon Advisors, LLC 962.19K Mar 31, 2026 2.65% $4.59 0.00%
Letko, Brosseau & Associates Inc. 953.18K Mar 31, 2026 2.62% $0.10 -1.80%
Rosalind Advisors, Inc. 828.12K Mar 31, 2026 2.28% $2.16 -22.53%
Mmcap International Inc. Spc 745.15K Mar 31, 2026 2.05% $0.42 40.23%
Ardsley Advisory Partners 575.00K Mar 31, 2026 1.58% $0.48 27.78%
Ring Mountain Capital, LLC 511.11K Mar 31, 2026 1.41% $1.81 12.56%
Royal Bank of Canada 493.06K Mar 31, 2026 1.36% $0.00 4.19%
Lagoda Investment Management LP 441.02K Mar 31, 2026 1.21% $1.76 0.00%
Arnhold & S. Bleichroeder Advisers, LLC 322.71K Mar 31, 2026 0.89% $0.00 3.20%
Velan Capital Investment Management LP 285.71K Mar 31, 2026 0.79% $1.16 0.00%
PARAGON Assoc & PARAGON Assoc II JV 276.00K Mar 31, 2026 0.76% $2.43 0.00%
Dafna Capital Management LLC 263.01K Mar 31, 2026 0.72% $0.39 -7.95%
Bleichroeder LP 254.75K Mar 31, 2026 0.70% $0.29 0.00%
Formula Growth Ltd 241.14K Mar 31, 2026 0.66% $0.71 18.84%
NATIONAL BANK OF CANADA /FI/ 217.18K Mar 31, 2026 0.60% $0.00 14.60%
Thompson Davis & Co Inc 215.79K Mar 31, 2026 0.59% $0.93 -0.44%

Shares Statistics

Shares Outstanding: 36.34M
Shares Float: 34.84M
% Insiders: 407.50%
% Institutions: 4,796.00%
Short % Float: 6.81%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity True North Cl F 1.98M 5.44% ▲ 14.49% Mar 31, 2026
2 Royce Micro-Cap Trust 691.02K 1.90% ▲ 15.05% Mar 31, 2026
3 Fidelity Canadian Equity Instl Tr 365.00K 1.00% ▲ 69.77% Mar 31, 2026
4 Royce Micro-Cap Invmt 322.57K 0.89% ▲ 10.23% Mar 31, 2026
5 First Eagle Small Cap Opportunity I 296.36K 0.82% ▲ 6.76% Apr 30, 2026
6 First Eagle US Small Cap Strategy 277.58K 0.76% ▲ 2.43% Mar 31, 2026
7 Royce Capital Micro-Cap Inv 102.76K 0.28% ▲ 5.84% Mar 31, 2026
8 North Growth Canadian Equity Series F 80.40K 0.22% ▲ 0.00% Mar 31, 2026
9 NEI Growth and Income A 30.20K 0.08% ▲ 0.00% Apr 30, 2026
10 First Eagle US Small Cap Opp I-UC 27.04K 0.07% ▲ 0.14% Apr 30, 2026

Valuation Metrics

Enterprise Value: $203.26M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $235.47M
EBITDA: $-37.61M
Book Value: $1.83
Earnings/Share: $-1.24
Profit Margin: -206.76%
Operating Margin: -150.29%
ROA (TTM): -35.47%
ROE (TTM): -70.59%
Revenue (TTM): $18.81M
Revenue/Share (TTM): $0.59
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 103.60%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 12.52x 0.05x 0.53x N/A -0.12x
2024-12-31 10.52x 0.08x 0.14x N/A -0.19x
2023-12-31 6.58x 0.24x 0.29x -37.16x -0.27x
2022-12-31 14.82x 0.14x 0.19x -192.25x -0.28x
2021-12-31 18.56x 0.00x 0.07x -456.12x -0.01x
2020-12-31 20.32x 0.00x 0.07x -34.74x -0.02x
2019-12-31 2.77x 0.76x 0.52x -14.36x -0.87x
2018-12-31 4.81x 0.59x 0.43x -19.63x -0.88x
2017-12-31 1.64x 0.37x 0.49x -16.45x -0.25x
2016-12-31 4.54x 0.53x 0.37x -25.40x -0.38x
2015-12-31 16.52x 0.57x 0.34x -2.77x -0.52x
2014-12-31 14.32x 0.61x 0.07x -30.34x -0.13x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PROF.US!